SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027269
Filing Date
2023-08-09
Accepted
2023-08-09 08:30:41
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1225257
2 ex31-1.htm EX-31.1 10716
3 ex31-2.htm EX-31.2 11198
4 ex32-1.htm EX-32.1 4559
5 ex32-2.htm EX-32.2 4587
  Complete submission text file 0001493152-23-027269.txt   6088276

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lixt-20230630.xsd EX-101.SCH 46560
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lixt-20230630_cal.xml EX-101.CAL 32535
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lixt-20230630_def.xml EX-101.DEF 244123
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lixt-20230630_lab.xml EX-101.LAB 345811
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lixt-20230630_pre.xml EX-101.PRE 284212
51 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 996663
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 231153502
SIC: 2834 Pharmaceutical Preparations